A team of researchers plans to analyze genes of more than 33,000 people in Hong Kong and China's Guangdong province to identify gene variants that play a role in high cholesterol and heart disease among Chinese patients and are responsible for the population's poor response to commonly prescribed statins. "If we find that the [culprit] genes [in Chinese patients] are different, it means what works for Western populations won't work for us. If we find that a different set of genes may be responsible for high cholesterol, we may need a different drug," said Tse Hung-fat, the lead researcher.

Full Story:

Related Summaries